share_log

Chengdu Bright Eye Hospital Co., Ltd.'s (SZSE:301239) Market Cap Increased by CN¥372m, Insiders Receive a 44% Cut

Chengdu Bright Eye Hospital Co., Ltd.'s (SZSE:301239) Market Cap Increased by CN¥372m, Insiders Receive a 44% Cut

成都明目医院股份有限公司(深证股份编号:301239)市值增加37200万元人民币,内部人员接受了44%的削减。
Simply Wall St ·  07/17 19:57

Key Insights

主要见解

  • Insiders appear to have a vested interest in Chengdu Bright Eye Hospital's growth, as seen by their sizeable ownership
  • The top 3 shareholders own 50% of the company
  • Institutions own 29% of Chengdu Bright Eye Hospital
  • 内部人士似乎对成都明目眼科医院的增长有着固执的利益,这可以从他们的庞大所有权中看出。
  • 前 3 名股东拥有公司的 50%。
  • 机构拥有成都明目眼科医院的29%股份。

Every investor in Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239) should be aware of the most powerful shareholder groups. With 44% stake, individual insiders possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

成都明目眼科医院有限公司(SZSE:301239)的每位投资者都应该知道最强大的股东群体。由于个人内部人士持有44%的股份,所以这个群体在公司中持有最多的股份。也就是说,如果股票上涨,他们将获得最大的利益(或者如果出现衰退,则承受最大的损失)。

As a result, insiders were the biggest beneficiaries of last week's 7.5% gain.

因此,内部人士是上周7.5%涨幅的最大受益者。

Let's take a closer look to see what the different types of shareholders can tell us about Chengdu Bright Eye Hospital.

让我们仔细观察一下不同类型的股东对成都明目眼科医院的影响。

big
SZSE:301239 Ownership Breakdown July 17th 2024
SZSE:301239所有权分布图(2024年7月17日)

What Does The Institutional Ownership Tell Us About Chengdu Bright Eye Hospital?

机构所有权对成都明目眼科医院有什么意义?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

许多机构衡量其业绩的标准是一个近似于当地市场的指数。因此,他们通常更加关注包括在主要指数中的公司。

Chengdu Bright Eye Hospital already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Chengdu Bright Eye Hospital, (below). Of course, keep in mind that there are other factors to consider, too.

成都明目眼科医院的股份登记簿上已经有了机构。的确,他们在公司中拥有可观的股份。这表明公司在投资界有一定的信誉。然而,最好谨慎地依赖机构投资者所谓的认可。他们也会有错误。如果两个大型机构投资者同时试图卖出股票,往往会看到股价大幅下跌。因此,值得检查成都明目眼科医院的过去收益轨迹(如下所示)。当然,也要记住还有其他因素需要考虑。

big
SZSE:301239 Earnings and Revenue Growth July 17th 2024
SZSE:301239收入和营收增长(2024年7月17日)

Chengdu Bright Eye Hospital is not owned by hedge funds. The company's largest shareholder is Xuyang Xu, with ownership of 43%. Fusui Zhengxin Investment Partnership Enterprise (Limited Partnership) is the second largest shareholder owning 4.0% of common stock, and Fusui Jinguan Qingcheng Investment Partnership Enterprise (Limited Partnership) holds about 3.1% of the company stock.

成都明目眼科医院没有被对冲基金所拥有。该公司最大的股东是许旭阳,持有43%的所有权,而福建知行投资合伙企业(有限合伙)持有普通股的4.0%,福建福瑞景冠清诚投资合伙企业(有限合伙)则拥有公司股份的约3.1%。

To make our study more interesting, we found that the top 3 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

总的来说,包括散户投资者在内,公众拥有公司的14%的股份,因此不能轻易忽视。尽管这种所有权的规模可能不足以在他们的利益方面影响政策决策,但他们仍然可以对公司政策产生集体影响。

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage.

尽管有必要研究公司的机构持股数据,但研究分析师的情绪也是有道理的,以了解风向。这只股票有一些分析师的覆盖,但不多。因此,有提高更多的分析涵盖面的空间。

Insider Ownership Of Chengdu Bright Eye Hospital

成都明目眼科医院的内部人士所有权

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

内部人员的定义在不同国家之间可能略有不同,但董事会成员始终计数。公司管理层回答董事会,在此应代表股东利益。值得注意的是,有时高级管理人员也在董事会上。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多数人认为内部所有权是积极的,因为它可以表示董事会与其他股东的利益相一致。但是,在某些场合下,这个团体的权力过于集中。

Our information suggests that insiders maintain a significant holding in Chengdu Bright Eye Hospital Co., Ltd.. Insiders own CN¥2.4b worth of shares in the CN¥5.4b company. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

我们的信息显示,内部人士在成都明目眼科医院股份有重要持股。内部人士在该54亿元公司中拥有24亿元的股份。这可能意味着创始人仍然拥有大量股份。你可以点击这里查看他们是否一直在买卖。

General Public Ownership

一般大众所有权

With a 18% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Chengdu Bright Eye Hospital. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

普通公众拥有18%的所有权,这主要由个人投资者组成,他们对成都明目眼科医院有一定的影响力。虽然这种所有权的规模可能不足以在政策决策方面发挥影响力,却仍然能够对公司政策产生集体影响。

Private Company Ownership

私有公司的所有权

Our data indicates that Private Companies hold 8.9%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我们的数据表明,私人公司持有该公司8.9%的股份。仅从这个事实本身很难得出任何结论,因此值得进一步了解持有这些私人公司的人。有时,内部人或其他相关方可能通过单独的私人公司持有一家上市公司的股份。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. For example, we've discovered 2 warning signs for Chengdu Bright Eye Hospital that you should be aware of before investing here.

《考虑拥有一家公司的不同群体》虽然考虑拥有公司的不同群体是值得的,但是还有更重要的因素。例如,我们发现了成都明目眼科医院的两个警示信号,您在在这里投资之前,应该注意它们。

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

如果您想发现分析师对未来增长的预测,请不要错过这份有关分析师预测的免费报告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?对内容感到担忧?请直接与我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈?对内容感到担忧?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发